216 related articles for article (PubMed ID: 31352106)
21. Surgical vein graft preparation promotes cellular dysfunction, oxidative stress, and intimal hyperplasia in human saphenous vein.
Osgood MJ; Hocking KM; Voskresensky IV; Li FD; Komalavilas P; Cheung-Flynn J; Brophy CM
J Vasc Surg; 2014 Jul; 60(1):202-11. PubMed ID: 23911244
[TBL] [Abstract][Full Text] [Related]
22. Surface-fill H
Chen X; Huang X; Liu C; Li S; Yang Z; Zhang F; Chen X; Shan H; Tao L; Zhang M
Acta Biomater; 2022 Dec; 154():259-274. PubMed ID: 36402296
[TBL] [Abstract][Full Text] [Related]
23. Vein interposition cuffs decrease the intimal hyperplastic response of polytetrafluoroethylene bypass grafts.
Kissin M; Kansal N; Pappas PJ; DeFouw DO; Durán WN; Hobson RW
J Vasc Surg; 2000 Jan; 31(1 Pt 1):69-83. PubMed ID: 10642710
[TBL] [Abstract][Full Text] [Related]
24. SKF38393 prevents high glucose (HG)-induced endothelial dysfunction by inhibiting the effects of HG on cystathionine γ-lyase/hydrogen sulfide activity and via a RhoA/ROCK1 pathway.
Chang GQ; Bai SZ; Sun FQ; Wu R; Wei C; Wen X; Xi YX; Hao JH; Zaid A; Li HZ
Front Biosci (Landmark Ed); 2022 Feb; 27(2):49. PubMed ID: 35226992
[TBL] [Abstract][Full Text] [Related]
25. Cyclic adenosine monophosphate response-element binding protein activation by mitogen-activated protein kinase-activated protein kinase 3 and four-and-a-half LIM domains 5 plays a key role for vein graft intimal hyperplasia.
Nakanishi K; Saito Y; Azuma N; Sasajima T
J Vasc Surg; 2013 Jan; 57(1):182-93, 193.e1-10. PubMed ID: 23127979
[TBL] [Abstract][Full Text] [Related]
26. Biological thiols-triggered hydrogen sulfide releasing microfibers for tissue engineering applications.
Feng S; Zhao Y; Xian M; Wang Q
Acta Biomater; 2015 Nov; 27():205-213. PubMed ID: 26363376
[TBL] [Abstract][Full Text] [Related]
27. BET Bromodomain Blockade Mitigates Intimal Hyperplasia in Rat Carotid Arteries.
Wang B; Zhang M; Takayama T; Shi X; Roenneburg DA; Kent KC; Guo LW
EBioMedicine; 2015 Nov; 2(11):1650-61. PubMed ID: 26870791
[TBL] [Abstract][Full Text] [Related]
28. Adventitial delivery of miR-145 to treat intimal hyperplasia post vascular injuries through injectable and in-situ self-assembling peptide hydrogels.
Zhao J; Wu S; Zhang M; Hong X; Zhao M; Xu S; Ji J; Ren K; Fu G; Fu J
Acta Biomater; 2024 Jan; 173():247-260. PubMed ID: 37939818
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of N-cadherin retards smooth muscle cell migration and intimal thickening via induction of apoptosis.
Lyon CA; Koutsouki E; Aguilera CM; Blaschuk OW; George SJ
J Vasc Surg; 2010 Nov; 52(5):1301-9. PubMed ID: 20630685
[TBL] [Abstract][Full Text] [Related]
30. A novel cell permeant peptide inhibitor of MAPKAP kinase II inhibits intimal hyperplasia in a human saphenous vein organ culture model.
Lopes LB; Brophy CM; Flynn CR; Yi Z; Bowen BP; Smoke C; Seal B; Panitch A; Komalavilas P
J Vasc Surg; 2010 Dec; 52(6):1596-607. PubMed ID: 20864298
[TBL] [Abstract][Full Text] [Related]
31. Vascular smooth muscle cell-derived hydrogen sulfide promotes atherosclerotic plaque stability via TFEB (transcription factor EB)-mediated autophagy.
Chen Z; Ouyang C; Zhang H; Gu Y; Deng Y; Du C; Cui C; Li S; Wang W; Kong W; Chen J; Cai J; Geng B
Autophagy; 2022 Oct; 18(10):2270-2287. PubMed ID: 35090378
[TBL] [Abstract][Full Text] [Related]
32. Hydrophilic statin suppresses vein graft intimal hyperplasia via endothelial cell-tropic Rho-kinase inhibition.
Yamanouchi D; Banno H; Nakayama M; Sugimoto M; Fujita H; Kobayashi M; Kuwano H; Komori K
J Vasc Surg; 2005 Oct; 42(4):757-64. PubMed ID: 16242565
[TBL] [Abstract][Full Text] [Related]
33. Connexin43 Inhibition Prevents Human Vein Grafts Intimal Hyperplasia.
Longchamp A; Allagnat F; Alonso F; Kuppler C; Dubuis C; Ozaki CK; Mitchell JR; Berceli S; Corpataux JM; Déglise S; Haefliger JA
PLoS One; 2015; 10(9):e0138847. PubMed ID: 26398895
[TBL] [Abstract][Full Text] [Related]
34. Effect of hydrogen sulfide on restenosis of peripheral arteries after angioplasty.
Ma B; Liang G; Zhang F; Chen Y; Zhang H
Mol Med Rep; 2012 Jun; 5(6):1497-502. PubMed ID: 22470131
[TBL] [Abstract][Full Text] [Related]
35. Linker-Regulated H
Kaur K; Wang Y; Matson JB
Biomacromolecules; 2020 Mar; 21(3):1171-1178. PubMed ID: 32053359
[TBL] [Abstract][Full Text] [Related]
36. Wall shear stress promotes intimal hyperplasia through the paracrine H
Zhang H; Yang Z; Wang J; Wang X; Zhao Y; Zhu F
Life Sci; 2018 Aug; 207():61-71. PubMed ID: 29847774
[TBL] [Abstract][Full Text] [Related]
37. Photodynamic therapy of vein grafts: suppression of intimal hyperplasia of the vein graft but not the anastomosis.
LaMuraglia GM; Klyachkin ML; Adili F; Abbott WM
J Vasc Surg; 1995 Jun; 21(6):882-90; discussion 889-90. PubMed ID: 7776467
[TBL] [Abstract][Full Text] [Related]
38. Vascular smooth muscle cells in intimal hyperplasia, an update.
Déglise S; Bechelli C; Allagnat F
Front Physiol; 2022; 13():1081881. PubMed ID: 36685215
[TBL] [Abstract][Full Text] [Related]
39. P2Y11 Agonism Prevents Hypoxia/Reoxygenation- and Angiotensin II-Induced Vascular Dysfunction and Intimal Hyperplasia Development.
Piollet M; Sturza A; Chadet S; Gabillard-Lefort C; Benoist L; Muntean DM; Aburel OM; Angoulvant D; Ivanes F
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33467058
[TBL] [Abstract][Full Text] [Related]
40. Modulation of phosphatidylinositol 3-kinase signaling reduces intimal hyperplasia in aortocoronary saphenous vein grafts.
Hata JA; Petrofski JA; Schroder JN; Williams ML; Timberlake SH; Pippen A; Corwin MT; Solan AK; Jakoi A; Gehrig TR; Kontos CD; Milano CA
J Thorac Cardiovasc Surg; 2005 Jun; 129(6):1405-13. PubMed ID: 15942585
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
